(Q83948766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

main subject

angiogenesis inhibitor

1 reference

T Klink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C Bela

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Stoelting

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S O Peters

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

R Broll

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

T Wagner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

8 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

643-652

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-006-0112-x

29 January 2020

exact match

0 references

cites work

Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature

1 reference

12 December 2020

Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA

1 reference

12 December 2020

Improved program for the analysis of DNA histograms.

1 reference

12 December 2020

New insights into the clinical pharmacokinetics of trofosfamide.

1 reference

12 December 2020

Quantification of cells cultured on 96-well plates

1 reference

12 December 2020

A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance.

1 reference

12 December 2020

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

1 reference

12 December 2020

Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts

1 reference

12 December 2020

Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.

1 reference

12 December 2020

Topical application of methotrexate for inhibition of corneal angiogenesis

1 reference

12 December 2020

Downregulation of protein kinase cdelta activity enhances endothelial cell adaptation to hypoxia

1 reference

12 December 2020

Palliative chemotherapy in pretreated patients with advanced cancer: oral trofosfamide is effective in ovarian carcinoma

1 reference

12 December 2020

Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.

1 reference

12 December 2020

Redefining the target: chemotherapeutics as antiangiogenics

1 reference

12 December 2020

Trofosfamide metabolism in different species--ifosfamide is the predominant metabolite

1 reference

12 December 2020

Trofosfamide in patients with pancreatic cancer.

1 reference

12 December 2020

Ultraviolet-induced detection of halogenated pyrimidines: simultaneous analysis of DNA replication and cellular markers

1 reference

12 December 2020

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

12 December 2020

Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

1 reference

12 December 2020

Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic

1 reference

12 December 2020

Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

1 reference

12 December 2020

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism

1 reference

12 December 2020

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

1 reference

12 December 2020

Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors

1 reference

12 December 2020

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

1 reference

12 December 2020

Trofosfamide in the treatment of patients with cancer. A pilot trial

1 reference

12 December 2020

Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer

1 reference

12 December 2020

10.1007/S00432-006-0112-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761121%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference